Effects of silencing of HER2/neu gene in anti-BPDE-transformed cells

Long-term spatiotemporal variation and lung cancer risk of atmospheric polycyclic aromatic hydrocarbons (PAHs) in the Yangtze River Delta, China

The Yangtze River Delta (YRD), which is the most developed region in China, suffers from atmospheric polycyclic aromatic hydrocarbons (PAH) pollution. However, the long-term spatiotemporal variation of atmospheric PAHs and the lung cancer risk caused by PAH exposure in the YRD remain unclear. Herein, we simulated the daily atmospheric concentration of benzo[a]pyrene (BaP, the most carcinogenic PAH) from 2001 to 2016 using an atmospheric transport model. During this period, the atmospheric BaP concentration showed a general trend of first increasing and then decreasing (average BaP concentration = 0.50 ± 0.12 ng/m³) and was highest in 2005 (0.72 ng/m³). Moreover, the BaP concentration in Jiangsu and Shanghai was 5.17- and 4.98-fold higher than that in Zhejiang. BaP pollution was severe in Jiangsu during the winter. The average area proportion of BaP exceeding the national standard in winter in Jiangsu was 69.09%. The population-weighted incremental lifetime cancer risk from 2001 to 2016 ranged 6.67 × 10^-6-1.50 × 10^-5, and the excess lung cancer cases ranged 1054-2130. Compared with 2005, excess lung cancer cases in the YRD decreased by 49.49% in 2016. Reducing BaP pollution in winter in Jiangsu is crucial for reducing lung cancer risk in the YRD.

Proteome Changes of Human Bone Marrow Mesenchymal Stem Cells Induced by 1,4-Benzoquinone

Benzene is metabolized to hydroquinone in liver and subsequently transported to bone marrow for further oxidization to 1,4-benzoquinone (1,4-BQ), which may be related to the leukemia and other blood disorders. In the present study, we investigated the proteome profiles of human primary bone marrow mesenchymal stem cells (hBM-MSCs) treated by 1,4-BQ. We identified 32 proteins that were differentially expressed. Two of them, HSP27 and Vimentin, were verified at both mRNA and protein levels and their cellular localization was examined by immunofluorescence. We also found increased mRNA level of RAP1GDS1, a critical factor of metabolism that has been identified as a fusion partner in various hematopoietic malignancies. Therefore, these differentially expressed proteins can play important roles in benzene-mediated hematoxicity.

RNAi knockdown of C-erbB2 expression inhibits salivary gland adenoid cystic carcinoma SACC-83 cell growth in vitro

OBJECTIVE

To knockdown the C-erbB2 gene in salivary gland adenoid cystic carcinoma SACC-83 cells using RNA interference, and determine the effect of silencing C-erbB2 on cell proliferation.

METHODS

C-erbB2-siRNA was transfected into SACC-83 cells. RT-PCR and immunohistochemistry were used to detect C-erbB2 expression in SACC-83 cells. Cell proliferation was measured by the MTT assay and gene knockdown was achieved by RNA interference. Apoptosis was analyzed by flow cytometry.

RESULTS

Compared with the control, C-erbB2 mRNA expression was decreased in the C-erbB2-siRNA transfection group, and immunohistochemical analysis indicated that C-erbB2 protein expression was decreased. After C-erbB2-siRNA was transfected for 48 h, absorbance at 570 nm (MTT) was 0.185±0.021 compared with 0.354±0.034, 0.299±0.053, and 0.314±0.049 in the blank control, liposome control and negative control siRNA groups, respectively. The differences were statistically significant (P < 0.05) between the C-erbB2-siRNA group and the control groups. Following the C-erbB2 knockdown, the percentage of apoptotic cells was 5.63% compared with 2.04%, 2.85%, and 2.98% in the three control groups, respectively. Proliferation of SACC-83 cells was inhibited, and early apoptotic cells were increased.

CONCLUSION

RNA interference can effectively silence C-erbB2 gene expression and inhibit growth of SACC-83 cells, which indicates the potential of targeting this gene as a novel gene therapy approach for the treatment of salivary gland adenoid cystic carcinoma.